Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuxi Shuangliang Biotechnology is a specialized subsidiary of the Shuangliang Group, a prominent Chinese industrial conglomerate. The company focuses on the research, development, and industrial-scale production of high-value bio-based chemicals, pharmaceutical intermediates, and functional food ingredients. By utilizing advanced microbial fermentation and enzymatic catalysis platforms, it provides sustainable and efficient manufacturing solutions for the global life sciences market. The firm operates as a key component of Shuangliang Group's strategic pivot toward green technology and high-end healthcare materials. It leverages the parent group's extensive industrial infrastructure to offer both R&D and large-scale bio-manufacturing services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 无锡双良生物科技.